Stock image Oral Diabetes Medication page 2
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.25MB, 4032 × 3024 jpg
Prague, Czech Republic - JULY 10 2024: Dursea Box Of Medication With Desmopressin Active Substance By Egis Pharmaceuticals, Used For Treatment Of Diabetes Insipidus And Nocturnal Enuresis.
Image, 2.02MB, 3024 × 4032 jpg
Prague, Czech Republic - JULY 10 2024: Dursea Box Of Medication With Desmopressin Active Substance By Egis Pharmaceuticals, Used For Treatment Of Diabetes Insipidus And Nocturnal Enuresis.
Image, 2.02MB, 3024 × 4032 jpg
Prague,Czech Republic-August 7 2024: METFORMIN VIATRIS Box Of Medication With METFORMIN Active Substance By VIATRIS,used For Treatment Of Type 2 Diabetes
Image, 2.21MB, 3024 × 4032 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.39MB, 3024 × 4032 jpg
Prague, Czech Republic - July 9 2024: SITAGLIPTIN METFORMIN TEVA Box Of Tablets With SITAGLIPTIN And METFORMIN Active Substances By TEVA, Used For Treatment Of Type 2 Diabetes.
Image, 2.3MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.37MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 1.95MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.32MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.32MB, 3024 × 4032 jpg
Empagliflozin Molecule. It Is Antidiabetic Medication, SGLT2 Inhibitor. Skeletal Chemical Formula. Paper Packaging For Drugs. Vector Illustration
Vector, 0.31MB, 6547 × 3819 eps
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.37MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.24MB, 3024 × 4032 jpg
Prague,Czech Republic-August 10 2024: JENTADUETO Box Of Tablets With LINAGLIPTIN And METFORMIN Active Substances, Used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.17MB, 3024 × 4032 jpg
Prague,Czech Republic-August 10 2024: THIOGAMMA ORAL Box Of Medication With ALPHA-LIPOIC ACID Active Substance By WRWAG PHARMA,used For Treatment Of Diabetic Neuropathy,neuroprotection.
Image, 2.14MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.33MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.16MB, 4032 × 3024 jpg
Glibenclamide, Glyburide Molecule. Sulfonylurea Used In The Treatment Of Non Insulin Dependent Diabetes Mellitus. Structural Chemical Formula, Molecule Model. Vector Illustration
Vector, 0.43MB, 5590 × 4472 eps
Prague,Czech Republic-August 10 2024: GLICLAZID MYLAN Box Of Tablets With GLICLAZIDE Active Substance,used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.15MB, 4032 × 3024 jpg
Prague,Czech Republic-August 7 2024: JANUVIA Box Of Medication With SITAGLIPTIN Active Substance By MERCK,used For Treatment Of Type 2 Diabetes
Image, 2.45MB, 4032 × 3024 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.28MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.22MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.15MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.24MB, 3024 × 4032 jpg
Prague,Czech Republic-August 10 2024: THIOGAMMA ORAL Box Of Medication With ALPHA-LIPOIC ACID Active Substance By WRWAG PHARMA,used For Treatment Of Diabetic Neuropathy,neuroprotection.
Image, 2.25MB, 4032 × 3024 jpg
Prague, Czech Republic - JULY 10 2024: Dursea Box Of Medication With Desmopressin Active Substance By Egis Pharmaceuticals, Used For Treatment Of Diabetes Insipidus And Nocturnal Enuresis.
Image, 2.07MB, 4032 × 3024 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.28MB, 4032 × 3024 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.24MB, 3024 × 4032 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.42MB, 4032 × 3024 jpg
Prague,Czech Republic-August 7 2024: VIPIDIA TAKEDA Box Of Medication With ALOGLIPTIN Active Substance By TAKEDA,used For Treatment Of Type 2 Diabetes
Image, 2.01MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.08MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.34MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.12MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.2MB, 4032 × 3024 jpg
Prague, Czech Republic - July 9 2024: SITAGLIPTIN METFORMIN TEVA Box Of Tablets With SITAGLIPTIN And METFORMIN Active Substances By TEVA, Used For Treatment Of Type 2 Diabetes.
Image, 2.32MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.38MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.26MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.02MB, 3024 × 4032 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.33MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.28MB, 4032 × 3024 jpg
Prague,Czech Republic-August 10 2024: GLICLAZID ACTAVIS Box Of Tablets With GLICLAZIDE Active Substance,used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.32MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.32MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.28MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.02MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.2MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.23MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.1MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: RYBELSUS Box Of Medication With SEMAGLUTIDE Active Substance By NOVO NORDISK, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.27MB, 3024 × 4032 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.23MB, 4032 × 3024 jpg
Prague, Czech Republic - July 9 2024: SITAGLIPTIN METFORMIN TEVA Box Of Tablets With SITAGLIPTIN And METFORMIN Active Substances By TEVA, Used For Treatment Of Type 2 Diabetes.
Image, 2.32MB, 3024 × 4032 jpg
Previous << Page 2 >> Next